{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T02:55:42Z","timestamp":1789095342596,"version":"build-2803163510"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Aim:<\/jats:title>\n                    <jats:p>This study aimed to investigate the relationship between nonalcoholic fatty pancreas disease (NAFPD) and metabolic dysfunction-associated steatotic liver disease (MASLD), and to evaluate the effects of pancreatic steatosis on clinical and laboratory parameters in patients aged 40\u201349 years. The secondary aim was to identify independent predictors of pancreatic steatosis and discuss their clinical relevance for early detection and prevention.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This retrospective single-center study included 132 patients aged 40\u201349 years who underwent abdominal magnetic resonance imaging (MRI). Pancreatic and hepatic fat fractions were measured using a chemical shift\u2013based MRI technique. Demographic data, comorbidities, and laboratory parameters were analyzed. Patients with a history of alcohol intake, pancreatitis, or incomplete data were excluded.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Pancreatic steatosis was present in 35.6% of participants. Patients with pancreatic steatosis had significantly higher rates of diabetes mellitus (59.6% vs. 21.2%), obesity (61.7% vs. 14.1%), hypertension (38.3% vs. 17.6%), and hyperlipidemia (44.7% vs. 20%) (all\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.01). Pancreatic steatosis was strongly associated with hepatic steatosis (80.9% vs. 11.8%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.001). Fasting glucose, HbA1c, HOMA-IR, and triglycerides were higher, whereas HDL and amylase were lower in the steatosis group. In multivariate logistic regression, diabetes mellitus (OR 8.06, 95% CI: 1.15\u201356.76,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =0.036) and HOMA-IR (OR 1.54, 95% CI: 1.19\u20131.99,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =0.001) were identified as independent predictors of pancreatic steatosis. Among patients with pancreatic steatosis, 80.9% also had hepatic steatosis, demonstrating a significant association between pancreatic and hepatic fat accumulation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>A significant association was found between pancreatic steatosis and metabolic risk factors such as diabetes, obesity, insulin resistance, and MASLD. MRI-based quantification provided accurate detection, supporting its value as the most reliable imaging modality for assessing pancreatic fat. Lifestyle interventions such as weight loss and physical activity may help mitigate pancreatic steatosis and related metabolic consequences. Further studies are needed to clarify causality and underlying pathways, such as lipotoxicity, inflammation, and \u03b2-cell dysfunction.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/mpa.0000000000002607","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T19:00:10Z","timestamp":1765825210000},"page":"e498-e507","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Investigation of Clinical and Laboratory Findings of 40\u201349-Year-Old Patients With Fatty Pancreas by Magnetic Resonance Imaging and Evaluation of the Potential Relationship With Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)"],"prefix":"10.1097","volume":"55","author":[{"given":"Hatice","family":"Demir","sequence":"first","affiliation":[{"name":"Internal Medicine Clinic, Ankara Training and Research Hospital, Ankara, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8693-7448","authenticated-orcid":false,"given":"Salim","family":"Tece","sequence":"additional","affiliation":[{"name":"Gastroenterology Clinic, Ankara Training and Research Hospital, Ankara, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan","family":"Yigit","sequence":"additional","affiliation":[{"name":"Department of Radiology, Ankara Training and Research Hospital, Ankara, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Levent","family":"Filik","sequence":"additional","affiliation":[{"name":"Gastroenterology Clinic, Ankara Training and Research Hospital, Ankara, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,5]]},"reference":[{"key":"R1-20260410","first-page":"107","article-title":"Pancreatic steatosis: diagnosis and clinical significance","volume":"1","author":"Da\u011fdeviren","year":"2017","journal-title":"J Contemp Med"},{"key":"R2-20260410","doi-asserted-by":"crossref","first-page":"547","DOI":"10.2174\/1871530318666180328111302","article-title":"Non-alcoholic fatty pancreas disease (NAFPD): a silent spectator or the fifth component of metabolic syndrome? A literature review","volume":"18","author":"Romana","year":"2018","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"R3-20260410","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.metabol.2016.12.012","article-title":"Ectopic fat accumulation in the pancreas and its clinical relevance: a systematic review, meta-analysis, and meta-regression","volume":"69","author":"Singh","year":"2017","journal-title":"Metabolism"},{"key":"R4-20260410","doi-asserted-by":"crossref","first-page":"7660","DOI":"10.3748\/wjg.v22.i34.7660","article-title":"Exploring the metabolic syndrome: nonalcoholic fatty pancreas disease","volume":"22","author":"Catanzaro","year":"2016","journal-title":"World J Gastroenterol"},{"key":"R5-20260410","doi-asserted-by":"crossref","first-page":"87","DOI":"10.14740\/gr731w","article-title":"Non-alcoholic fatty pancreatic disease: a review of literature","volume":"9","author":"Tariq","year":"2016","journal-title":"Gastroenterology Res"},{"key":"R6-20260410","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1097\/MPA.0b013e3181a9d5af","article-title":"Risk factors for hyperechogenic pancreas on endoscopic ultrasound: a case-control study","volume":"38","author":"Al-Haddad","year":"2009","journal-title":"Pancreas"},{"key":"R7-20260410","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.3748\/wjg.v17.i15.2061","article-title":"Pancreatic hyperechogenicity on endoscopic ultrasound examination","volume":"17","author":"Ustundag","year":"2011","journal-title":"World J Gastroenterol"},{"key":"R8-20260410","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1148\/027153330290051277","article-title":"Invited commentary","volume":"29","author":"Sirlin","year":"2009","journal-title":"Radiographics"},{"key":"R9-20260410","first-page":"987","article-title":"In-phase and out-of-phase MRI: a quantitative method for assessment of nonalcoholic fatty liver disease","volume":"33","author":"Hassanein","year":"2020","journal-title":"Menoufia Med J"},{"key":"R10-20260410","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/joim.12745","article-title":"The ageing pancreas: a systematic review of the evidence and analysis of the consequences","volume":"283","author":"L\u00f6hr","year":"2018","journal-title":"J Intern Med"},{"key":"R11-20260410","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/j.ejrad.2011.07.014","article-title":"Age-related changes in normal adult pancreas: MR imaging evaluation","volume":"81","author":"Sato","year":"2012","journal-title":"Eur J Radiol"},{"key":"R12-20260410","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/MPA.0b013e318201669f","article-title":"Noninvasive quantification of pancreatic fat in healthy male population using chemical shift magnetic resonance imaging: effect of aging on pancreatic fat content","volume":"40","author":"Li","year":"2011","journal-title":"Pancreas"},{"key":"R13-20260410","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/MPA.0b013e3182061583","article-title":"Effect of different obesogenic diets on pancreatic histology in Ossabaw miniature swine","volume":"40","author":"Fullenkamp","year":"2011","journal-title":"Pancreas"},{"key":"R14-20260410","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2337\/dc10-0760","article-title":"Ethnic differences in pancreatic fat accumulation and its relationship with other fat depots and inflammatory markers","volume":"34","author":"L\u00ea","year":"2011","journal-title":"Diabetes Care"},{"key":"R15-20260410","doi-asserted-by":"crossref","first-page":"e000297","DOI":"10.1161\/JAHA.113.000297","article-title":"Enigmatic ectopic fat: prevalence of nonalcoholic fatty pancreas disease and its associated factors in a Chinese population","volume":"3","author":"Wang","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"R16-20260410","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1475-2840-12-77","article-title":"Association between non-alcoholic fatty pancreatic disease (NAFPD) and the metabolic syndrome: case-control retrospective study","volume":"12","author":"Wu","year":"2013","journal-title":"Cardiovasc Diabetol"},{"issue":"Suppl 2","key":"R17-20260410","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1467-789X.2012.01035.x","article-title":"Visceral fat and metabolic inflammation: the portal theory revisited","volume":"13","author":"Item","year":"2012","journal-title":"Obes Rev"},{"key":"R18-20260410","doi-asserted-by":"crossref","first-page":"110","DOI":"10.2174\/1570161117666190405165151","article-title":"Macrovascular complications of type 2 diabetes mellitus","volume":"18","author":"Viigimaa","year":"2020","journal-title":"Curr Vasc Pharmacol"},{"key":"R19-20260410","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.2918","article-title":"Ectopic fat accumulation in the pancreas and its biomarkers: a systematic review and meta-analysis","volume":"33","author":"Singh","year":"2017","journal-title":"Diabetes Metab Res Rev"},{"key":"R20-20260410","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s10620-021-06844-3","article-title":"Pancreatic steatosis is associated with both metabolic syndrome and pancreatic stiffness detected by ultrasound elastography","volume":"67","author":"Sezgin","year":"2022","journal-title":"Dig Dis Sci"},{"key":"R21-20260410","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.3748\/wjg.15.1869","article-title":"Clinical implications of fatty pancreas: correlations between fatty pancreas and metabolic syndrome","volume":"15","author":"Lee","year":"2009","journal-title":"World J Gastroenterol"},{"key":"R22-20260410","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/ajg.2014.1","article-title":"Fatty pancreas, insulin resistance, and beta-cell function: a population study using fat-water magnetic resonance imaging","volume":"109","author":"Wong","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"R23-20260410","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/hep.24706","article-title":"Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease","volume":"55","author":"Kowdley","year":"2012","journal-title":"Hepatology"},{"key":"R24-20260410","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1475-2840-10-34","article-title":"Low serum amylase in association with metabolic syndrome and diabetes: A community-based study","volume":"10","author":"Nakajima","year":"2011","journal-title":"Cardiovasc Diabetol"},{"key":"R25-20260410","doi-asserted-by":"crossref","first-page":"107974","DOI":"10.1016\/j.diabres.2019.107974","article-title":"Low serum amylase, lipase, and trypsin as biomarkers of metabolic disorders: a systematic review and meta-analysis","volume":"159","author":"Ko","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"key":"R26-20260410","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1097\/MPA.0b013e3181f6fce2","article-title":"Nonalcoholic fatty liver disease is related to nonalcoholic fatty pancreas disease","volume":"39","author":"van Geenen","year":"2010","journal-title":"Pancreas"}],"container-title":["Pancreas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPA.0000000000002607","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T15:00:26Z","timestamp":1775833226000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPA.0000000000002607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,15]]},"references-count":26,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/mpa.0000000000002607","relation":{},"ISSN":["1536-4828"],"issn-type":[{"value":"1536-4828","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,15]]},"assertion":[{"value":"2025-07-08","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-28","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}